This purchase includes development rights for 35MW of wind power capacity, reflecting the company’s commitment to renewable energy and lowering costs.
“This acquisition serves as a blueprint for how the energy and data center sectors can collaborate to create long-term value while advancing sustainability initiatives,” said Fred Thiel, MARA’s Chairman and CEO.
<script type="application/ld+json">
{
"@context": "https://schema.org",
"@type": "Article",
"mainEntityOfPage": {
"@type": "WebPage",
"@id": "https://www.themoney.game/stories/mara-acquires-wind-farm-to-drive-sustainable-digital-asset-operations"
},
"headline": "MARA Acquires Wind Farm to Drive Sustainable Digital Asset Operations",
"description": "This purchase includes development rights for 35MW of wind power capacity, reflecting the company’s commitment to renewable energy and lowering costs.",
"image": "",
"author": {
"@type": "Organization",
"name": "The Money Game",
"url": "https://www.themoney.game"
},
"publisher": {
"@type": "Organization",
"name": "",
"logo": {
"@type": "ImageObject",
"url": ""
}
},
"datePublished": "2024-12-04"
}
</script>
Actions
Pages
Subscribe for newsletter
Stories
SkyNRG, a global leader in Sustainable Aviation Fuels (SAF), has secured a €175 million investment from Macquarie Asset Management.
The Amsterdam-based company has led the development of SAF in the aviation industry, notably powering the first commercial flight with SAF. This funding is critical to accelerate efforts in reducing carbon emissions in aviation, which accounts for 2.5% of global CO2 emissions. SkyNRG is one of the firms dedicated to attaining the shared objective of airlines achieving carbon neutrality by 2050.
Philippe Lacamp, CEO of SkyNRG, commented, “We are very proud that Macquarie has made this strategic investment in our business and are confident that they, with the ongoing support of our existing shareholders, will provide us with the resources and expertise we need to accelerate our growth journey towards becoming a major player in the SAF industry.”
The investment aligns with global initiatives like the European ReFuelEU mandate and the U.S. Inflation Reduction Act, highlighting the increasing political and regulatory support for SAF.
Story
Businesses in Canada may be able to create high value revenue-generating compliance carbon credits when they replace ICE vehicle fleets with EVs. Canada launched a new carbon credit system with the introduction of the Clean Fuel Regulations (CFR) and amendments to British Columbia's Low Carbon Fuel Standard (LCFS) program. This new system, which integrates federal and provincial regulations, is designed to incentivize businesses to to transition to low-carbon fuels and adopt EV fleets.
The government is tapping into a market-driven solution to establish a dynamic credit market where existing fossil fuel suppliers become the buyers of compliance credits created by new EV fleet purchasers.
The future likely holds more stringent carbon intensity targets, increased adoption of EVs by businesses, and further expansion of the carbon credit market, potentially influencing global environmental policies.
While the shift towards EVs and low-carbon fuels is beneficial, it raises questions about the readiness of existing infrastructure to support a rapid transition and the impact on traditional fuel industries.
Story
Vivodyne, a biotech research startup, has announced $38 million in funding led by Khosla Ventures. Vivodyne leverages AI-scale testing on lab-grown human organs for preclinical testing for every stage of drug development.
Vivodyne enables their biopharma partners to see human data even before clinical trials and reduces the need for animal testing. Their platform can mimic drug interactions with human cells offering more precise results, enhance drug success rates and accelerate the discovery of more effective treatments.
“We’re thrilled to have Khosla Ventures lead this funding round, which accelerates the development of our AI platform that enables the generation of predictive human data before therapeutics enter clinical trials,” said Andrei Georgescu, CEO and Co-Founder of Vivodyne.
Vivodyne plans to expand its platform and potentially collaborate with top biopharma companies. This expansion aims to advance AI-driven drug discovery using its extensive human data sets.
Story
Innovators
Scroll
Open
Close